BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 37 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,858 | -15.3% | 6,110 | -30.4% | 0.47% | -24.9% |
| Q2 2023 | $6,920 | -36.8% | 8,785 | -40.6% | 0.63% | -32.0% |
| Q1 2023 | $10,956 | +38.9% | 14,785 | -13.2% | 0.92% | +59.4% |
| Q4 2022 | $7,890 | -99.9% | 17,035 | +3.0% | 0.58% | -11.9% |
| Q3 2022 | $9,736,000 | -10.6% | 16,535 | -17.5% | 0.66% | -15.9% |
| Q2 2022 | $10,895,000 | +10.6% | 20,035 | +21.5% | 0.78% | +21.7% |
| Q1 2022 | $9,850,000 | -6.9% | 16,489 | +13.6% | 0.64% | -22.5% |
| Q4 2021 | $10,578,000 | +53.1% | 14,515 | +190.3% | 0.83% | +17.0% |
| Q3 2021 | $6,911,000 | +110.1% | 5,000 | +150.0% | 0.71% | +131.5% |
| Q2 2021 | $3,290,000 | – | 2,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 17,000,000 | $16,407,550 | 4.62% |
| BRAIDWELL LP | 114,338,000 | $109,764,480 | 3.47% |
| Castle Creek Arbitrage, LLC | 10,000,000 | $9,635,000 | 2.27% |
| ARISTEIA CAPITAL, L.L.C. | 67,223,000 | $64,534,080 | 1.74% |
| Graham Capital Management, L.P. | 55,529,000 | $53,481,723 | 1.26% |
| 683 Capital Management, LLC | 14,750,000 | $14,186,550 | 1.10% |
| TFG Asset Management GP Ltd | 5,850,000 | $5,622,500 | 1.02% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,875,000 | $21,039,375 | 0.87% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 33,421,000 | $32,084,160 | 0.75% |
| Context Capital Management, LLC | 6,110 | $5,858 | 0.47% |